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Although scientists have known since the
early 1900s that occupational exposure to
certain chemicals can induce severe
immune effects, recent chemical disasters
of national and international prominence
have renewed interest in the subject. It is
generally agreed that human health is
influenced by the environment and that
many diseases are caused or enhanced by
environmental factors, but effects on the
immune system have been difficult to
delineate. Researchers in the field of
immunotoxicology, who study the adverse
effects to immune function that result
from occupational, inadvertant, or thera-
peutic exposure to environmental chemi-
cals, biological materials, and drugs, debate
if toxicants damage the immune system
and to what extent. Some researchers con-
tend that certain chemicals can affect
immunity, significantly increasing an indi-
vidual's susceptibility to disease, in some
cases causing hypersensitivity reactions,
autoimmunity, or immunosuppression.
Others dispute this view, arguing that the
evidence for immunotoxicity in humans is
greatly overstated.
To Serve and Protect
The immune system is the body's complex
surveillance network whose mission is to
recognize and destroy disease-causing or
"foreign" agents. It contains millions of
highly specialized cells in the
bloodstream and various tis-
sues designed for this purpose.
When the body is invaded by
foreign substances such as
viruses and bacteria, the appro-
priate immune cells respond
by destroying the foreign mat-
ter or rendering it harmless.
When parts of the immune
system are damaged, the body
cannot fight its adversaries andci
conditions and diseases rang-
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mune system has developed a number of
important attributes. Each individual's
immune system is distinctive, causing
enemy agents and immune cells to interact
differently from person to person, thanks to
a unique set of molecules on the surface of
immune cells called antigens. The healthy
immune system can discriminate the body's
own antigens, known as self, from foreign
antigens, known as nonself. Not only can
the immune system detect millions of non-
selfantigens, it can produce armies ofcellu-
lar and chemical mediators to launch an
initial attack against a foreign substance and
manufacture great numbers of specialized
cells in the process. The immune system is
able to "remember" foreign antigens once
the attack is over so that immune responses
are activated more rapidly if exposure to a
particular antigen reoccurs. This rapid
recall is the basis for protection against anti-
gens by vaccination.
Cells designed to develop into immune
cells are produced in the bone marrow in a
process called lymphopoiesis. These
immune cells, called leukocytes or white
blood cells, include a variety of specialized
cells: macrophages, eosinophils, natural
killer (NK) cells, plasma cells, and T- and
B-lymphocytes. The development of these
various cell types is directed by chemicals
called cytokines. Some lymphocytes cluster
in immune organs including the thymus,
spleen, lymph nodes, tonsils,
= and adenoids, while others
_ flow continuously throughout
the body in the blood and
through a network of lym-
phatic vessels. The vessels
carry lymph to the lymph
nodes, the small bean-shaped
organs that store lymphocytes
and other immune cells. In
the lymph nodes, antigens are
filtered out and handed over
to immune cells and lymph
tflows back into the blood- -Age, genet-
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y. Lymphoid tissues are also pre-
sent in local groups known as bronchus-,
gut-, and skin-associated lymphoid tissue.
Immune cells manufacture a wide vari-
ety of chemical messengers that can
instruct and control other immune cells or
help to attack and destroy foreign antigens.
These chemicals include antibodies, which
are protein molecules capable ofcombining
with a foreign subtance, cytokines such as
interferon and interleukins, and comple-
ment, which consists ofproteins that act in
concert with antibodies.
The responses of the immune system
to the presence offoreign agents are divid-
ed into innate and acquired responses.
Innate immune responses can be thought
of as the first line of defense against for-
eign bodies carried out by all-purpose
immune cells such as particle-eating cells
like macrophages and neutrophils. NK
cells are also part of the innate response,
destroying any cells containing tumor or
viral antigens. Acquired immune responses
develop to attack specific infectious agents,
tumor cells, or allergens. Macrophages also
play a role in acquired immunity when
they process and present antigens to T-
lymphocytes, or T-cells, that work to
destroy specific antigens. There are differ-
ent types ofT-cells that play different roles
when the body is under attack. For exam-
ple, cytotoxic T-cells recognize and kill
cells containing viral or tumor antigens,
and suppressor T-cells decrease the
immune response when needed.
B-lymphocytes, or B-cells, also multiply
in the presence of a specific antigen, often
with the assistance ofT-cells. B-cells differ-
entiate into plasma cells that produce anti-
bodies that specifically bind to the antigen
of the invading foreign body. These anti-
bodies may also assist macrophages in
engulfing foreign bodies, rupture bacterial
cells, neutralize viruses, and facilitate the
cytotoxic activities ofNK cells.
Who's Susceptible?
According to Michael Luster, head of the
Environmental Immunology and Neuro-
biology Section of the NIEHS, age, genet-
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ics, preexisting disease, lifestyle, diet,
drugs, or stress may compound the effects
of chemical exposures to further compro-
mise immune function and increase the
chance ofdisease. Most ofthe evidence for
this interaction comes from animal stud-
ies, but there is evidence from human
observations as well. About 10% of the
U.S. population has a genetic tendency to
develop allergies. Studies have shown that
parents with allergies have a higher pro-
portion of children with allergies. In one
study, children born to allergic parents
had a 50% chance of being allergic; with
only one allergic parent, the chances were
still 30%. Normal immune response
depends on the collaboration ofmore than
60 genes.
It is thought that some immunologic
disorders surface even under ordinary envi-
ronmental conditions, while others appear
only after toxic challenges from the envi-
ronment that act to invoke a previously
undetected genetic condition. Genetic
studies have demonstrated the existence of
a receptor, called the Ah receptor for aro-
matic hydrocarbon responsiveness, in some
animals and humans that binds to halo-
genated aromatic hydrocarbons, or HAH.
This binding ofan HAH may cause toxici-
ty to immune cells, the liver, and DNA
and increase cancer risk.
Children and the elderly may be espe-
cially susceptible to reductions in immune
function. It is well known that the devel-
oping immune system is vulnerable to
chemical injury. Infants are born with only
passive immunity; that is, they are protect-
ed for a short period by maternal antibod-
ies that they receive through the placenta
and later from breast milk. Although stud-
ies of long-term, low-level exposures to
environmental toxicants have not been
done in the elderly, it is probable that
some of the health problems in this popu-
lation may be associated with reductions in
immune function.
Certain therapeutic drugs may also
damage immunity. Vitamins, antibiotics,
antifungal agents, replacement hormones,
diphenylhydantoin, and lithium are a few
of the drugs associated with immunologic
changes. Abused substances, including
alcohol, cocaine, and opioids, may be
immunotoxic as well.
Do Chemicals Injure Immunity?
Many immunotoxicologists say that expo-
sures to certain chemicals can have a signifi-
cant effect on immune function. Studies have
shown that chemical exposures can affect
immunity in two major ways: by causing
hypersensitivity reactions, including allergy,
which can be harmful to organs and tissues,
and autoimmunity, in which immune cells
attack self; or by causing immunosuppres-
sion, a reduction in the
responses and activities of the
immune system.
Hypersensitivity. Luster
has written that 35 million
Americans suffer from aller-
gies, of which 2-5% are due
to occupational chemical
exposure. In some individu-
als, certain substances can
aggravate the immune system
and cause it to overreact. The
first time that an allergy-
prone person is exposed to an' Mary Jane S
allergy-causing antigen (an cellular effec
allergen), the matching B- effects on h
cells generate the class ofanti- tions.
body called immunoglobulin
E (IgE). These IgE antibodies attach to the
surfaces of other immune cells known as
mast cells and basophils, which are found
in the lungs, skin, tongue, nose, and
intestinal tract. Upon second exposure to
the allergen, IgE antibodies on mast cells
or basophils signal the release ofchemicals
such as histamine, which is largely respon-
sible for the intense itching, watery eyes,
and runny noses that are commonly associ-
ated with allergies.
Some people have more severe allergic
reactions than others. Many chemicals
cause serious allergic responses beyond the
ordinary mild reactions. For example,
exposure to toluene diisocyanate (TDI),
used in the production of plastics and
resins, can result in both contact dermatitis
and asthma. Workers in the paint and plas-
tic industries exposed to trimetalic anhy-
drides had antigen-mediated asthma and
rhinitis, late respiratory systemic syn-
drome, and pulmonary disease anemia.
Other agents induce different types of
hypersensitivities. Metals can cause the
development of autoimmunity, in which
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_ self as nonself, and mounts an
aberrant assault. The result
can be an autoimmune disease
ofthe joints and kidneys, such
as rheumatoid arthritis,
K glomerulonephritis, and inter-
stitial nephritis, all of which
have been associated with
exposures to mercury, gold, or
lead. Other organ systems
such as the gastrointestinal
irade-We tract, blood and blood vessels,
rladte frWm the central nervous system,
n animals to and the thyroid, may be tar-
an popula- geted for chemically induced
autoimmunity.
Exposure to beryllium, a
metal used in the manufacture of copper
alloys and in the aerospace, nuclear, and
electronics industries, is associated with
delayed hypersensitivity, in which the
immune system reacts to antigen in an
immune cell that cannot be cleared or
digested. T-cells are then activated to
release substances called lymphokines,
which cause inflammation due to the
influx ofimmune cells and lymphocytes to
the site. With repeated exposures, cells
gather at the site of the metal and form
masses known as granulomas. When granu-
lomas collect in the lungs, the chronic lung
disease known as berylliosis sets in. Short-
term, high-concentration beryllium expo-
sure can also lead to dermatitis and sensiti-
zation to beryllium.
Immunosuppression. Immunosuppres-
sion is normally associated with drugs used
to treat autoimmune diseases and increase
the survivability ofan organ transplant. No
matter how closely an organ donor matches
an organ recipient, the new organ will have
some different antigens that may be per-
ceived by the immune system as foreign
agocytic
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Immune platoon. Specialized cells in the immune system fight offtoxic agents.
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bodies. Because the activities ofthe immune
system have been reduced, immunosup-
pressed patients are more susceptible to
infections and cancers.
A number of human studies cite evi-
dence that immunosuppression also occurs
in individuals exposed to environmental
agents. In the late 1970s, a group of dairy
farmers living in a small town in Michigan
who were affected by Hodgkin's disease
were also found to have been exposed to
polybrominated biphenyls. Children
exposed to industrial chemical-contaminat-
ed drinking water in the 1980s were
reported to have a higher incidence of
leukemia and recurrent infections, and
their family members had increased levels
of T-cells, antibodies directed against self
antigens, and repeated rashes. Taiwanese
individuals who ingested rice oil contami-
nated with polychlorinated biphenyls
(PCBs) and dibenzofurans exhibited
increased sinopulmonary infections and
altered T-cell functions. Other researchers
have reported incidence of "toxic oil syn-
drome," an immunosuppressive disease
that appears to also involve autoimmunity,
in Spanish residents who consumed rape-
seed oil containing imidazolidethion.
Evidence also shows that exposure to ultra-
violet radiation and ozone suppresses
Iatural ResistancE
(spontaneous)
immune responses in humans.
While the mechanism of
chemically induced immuno-
suppresion is not completely
understood, it appears that in
some cases hemotoxicity, direct
damage to the organs and prog-
enitor immune cells, is partially
responsible. Specifically, envi-
ronmental chemicals can affect
the process of hematopoeisis,
the production and maturation
of blood cells, including
immune cells. Environmental Michael H
agents can target stem cells, re- dard tests (
ducing the number ofcells avail- immunotox
able for maturation; affect the
marrow itself, rendering it nonfunctional;
or damage specific types of immune cells,
causing imbalances among cell types.
Organic solvents are well known for
their destructive effect on hematopoiesis.
Used in the paint and other industries,
benzene exposure can lead to abnormalities
in the numbers ofblood cell types, includ-
ing leukopenia, and bone marrow hyper-
plasia. In the past, exposures to heavy met-
als, in particular lead, was thought to only
affect red blood cells. Recently, studies
have shown that lead accumulates in the
bone marrow, reducing the number of
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War plans. Immune cells launch an attack on target cells through a variety of mechanisms.
_6 stem and other types of
cells. Another chemical,
dimethylnitrosamine, is a
_ potent inhibitor ofantibody
production.
HAHs such as 2,4-
dichlorophenoxyacetic acid
(2,4-D) and 2,4,5-trichloro-
phenoxylacetic acid, the
active ingredients in Agent
Orange, have multiple ef-
fects on immune functions.
TCDD (2,3,7,8-tetrachloro-
lolsapple-Stan- dibenzo-p-dioxin) is an
can't detect many HAH considered to be the
cicproblems. prototype dioxin. Dioxins
affect antibody production
and immune cell activities. They may also
cause immunosuppression and decreased
resistance to disease.
The Debate
The controversy over immunity focuses
mainly on the questions of whether envi-
ronmental and chemical agents can sup-
press the immune system in the general
population and, if so, if this reduction in
immune function can result in clinical dis-
ease. While animal toxicology data clearly
demonstrate such effects, many researchers
and clinicians in the field of immunotoxi-
cology believe that current evidence is not
sufficient to support the notion that
immunologic damage to humans occurs as
, the result of chemical exposures. Epi-
demiologic studies demonstrating such
immunotoxic effects have come under fire
from researchers who criticize, among
other things, lack of a complete or firm
immunodeficiency diagnosis, small patient
group sizes, and the inability to establish
actual exposure levels. These are problems
that have plagued epidemiology and toxi-
cology for decades, making it difficult to
evaluate the magnitude ofhealth problems
associated with occupational exposures or
the effects on the population at large.
Some point out that the immune sys-
tem, like every physiological system, proba-
bly has "reserve capacity," that is, enough
overlap in functions that small amounts of
injury are anticipated and absorbed. While
the possibility exists that high-dose toxin
exposures could cause significant changes,
"the immune system is resilient," says Jack
Dean, president of the research division of
Sanofi-Winthrop. "You need a lot ofinjury
before you can see an effect. There are very
few cases where the two can be linked," says
Dean. In a number of studies, immune
function was normal in individuals exposed
to high levels of immunotoxic chemicals,
including heavy metals and TCDD.
Another example is the Bhopal disaster, in
which individuals exposed to methyl iso-
cyanate, an intermediate chemical pro-
Environmental Health Perspectives
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duced in the manufacture of carbamate
pesticides, were found to have increases in
numbers of T-cells and decreases in cell
activity following exposure to methyl iso-
cyanate, but no clinical immunologic dis-
eases were reported. Neighbors of the
Michigan dairy farmers who were exposed
to polybrominated biphenyls had no
immune changes at all. Even in factory
workers exposed to benzene and other
organic solvents, the clinical relevance of
immune system changes is unclear.
Luster admits that the question of
whether environmental agents can decrease
immune function is difficult to answer
because the types of immunologic effects
one might expect in the general population
are probably subtle. "There is a lot of
immunologic variability between individu-
als; it would be hard to establish a 10 to 15
percent reduction in immune function,"
he says. To sort out the effects ofenviron-
mental agents, researchers agree that fur-
ther clinical studies using well-defined sub-
populations and the development ofsensi-
tive tests are needed. But opinions on what
the best approaches might be varywidely.
The value ofanimal models for collect-
ing data on immunotoxicity is even ques-
tioned, despite the fact that the majority of
data on immunotoxic chemicals comes
from such studies. In the past, some animal
studies were criticized because
the doses used were well beyond
what humans might be exposed
to except in cases of accidents,
but most researchers have recog-
nized this problem and adjusted
their studies. The problem of
how to extrapolate animal results
to humans still remains an issue.
"The challenge for risk assess-
ment is to extrapolate from
immunotoxicity testing, which is
usually a measure of cellular
effects in animals, to human Nancy Ker
s It rr t X I * more comn health effects at the population models.
level," says Mary Jane Selgrade,
Chief, Health Effects Research
Laboratory of the EPA Immunotoxicology
Branch. "We can do this qualitatively but
not quantitatively."
Research in animals has confirmed the
results of accidental exposures. The
immune systems of several laboratory ani-
mals are similar to that ofhumans in orga-
nization, function, and responsiveness,
including those ofmice and rats. Monkeys
chronically exposed to a mixture of PCBs
equivalent to that found in the environ-
ment became immunosuppressed: theyhad
aberrant ratios ofT-cell types and lowered
antibody responses. Moreover, immuno-
suppression was seen in the offspring that
were exposed perinatally. These immuno-
logical effects were similar to those report-
rkvi
npa
ed in individuals from Taiwan who were
exposed to PCB-contaminated rice oil.
Selgrade has developed a mouse model
to examine the relationship between chem-
ical suppression of natural killer cells
(which are nonspecific) and susceptibility
to cytomegalovirus infection. She adminis-
tered eight chemicals in various doses and
found that a significant correlation was
observed between chemical suppression of
natural killer cell activity against the virus
and an increased number ofdeaths due to
viral infection. Selgrade and others have
done similar studies with bacterial infec-
tions and their effect on lung immune
cells, specifically suppression of alveolar
macrophages in which phagocytosis corre-
lates with susceptibility to streptococcus
infection in the lung. In situations where
comparisons are possible between effect of
environmental agents on human and
mouse immune responses, she has found
that, "the mouse has predicted pretty well
what happens in humans."
Nancy Kerkvliet, associate professor in
the Department ofAgricultural Chemistry
at Oregon State University, cites another
problem with animal studies: most exam-
ine the spleen after exposure, whereas in
humans, blood tests are used to measure
immune impairment. "We need more
comparable models," says Kerkvliet.
_i Measurements of toxic
co effects to immunity in
humans rely on the use of
6 standard clinical tests,
which include measures of
antibody levels, the ability
of lymphocytes to prolifer-
ate, and responses of im-
mune cells to antigens. In a
few cases, such assays are
accepted as indicative of
exposure. Clinical evidence
of beryllium exposure is
iet-We need strongly associated with
immune activity against the
metal by T-lymphocytes
obtained from bronchoalve-
olar lavage or peripheral blood, for exam-
ple. However, these types of tests may not
be sensitive enough to assess immunotoxic
problems due to most low-level chemical
exposures. "You expect these effects to be
more subtle; we really can't depend on the
standard tests," says Michael Holsapple,
Research Associate of Dow Chemical, who
conducted a number ofTCDD studies in
animals. Others would go one step further
in questioning the validity ofsuch tests for
immunotoxicology. Says Dean, "It is not
clear how much of a change in functional
assay signals a difference in the immune
system.
It may be that the small changes
observed in the laboratory are often blown
out of proportion, according to Kerkvliet.
In addition, she says, little attention is paid
to the chemical exposures that appear to
increase immune system activity. "Except
in cases of autoimmunity and allergy, the
negative interpretations for this boost in
immunity may not necessarily be valid."
But immunotoxic damage in both humans
and animals happens "against a back-
ground of other factors," says Selgrade.
"Immunocompetence in the general popu-
lation probably is a bell-shaped curve. The
concern in immunotoxicity is most likely
those individuals that fall on the lower end
ofthe curve," she says.
Most immunotoxicologists would agree
that there is a need for more well-con-
trolled epidemiology studies in humans.
Holsapple suggests that better ways to
assess risk might be to look more closely at
chemical-exposed populations. For
instance, the administration of a flu vac-
cine to a dioxin-exposed population would
give direct information on how these indi-
viduals handle direct antigenic challenge.
Selgrade is involved in collaborative
research in which humans are exposed to
ozone by inhalation in order to quantify
alveolar macrophage responses and com-
pare them to the animal responses she has
studied. Similarly, following controlled
human exposures to ultraviolet radiation,
EPA studies have demonstrated immune
suppression that is similar to that observed
in mice. Says Holsapple: "We need to ask
more and more analogous questions in
humans to take advantage of what we've
learned in animals." Immunologists con-
tinue to struggle with these issues in
attempts to aid the risk assessment process
in a way that is meaningful for human
health.
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